메뉴 건너뛰기




Volumn 6, Issue , 2012, Pages 75-84

Treatment options in Cushing's disease

Author keywords

Bilateral adrenalectomy; Cushing's disease; Medical therapy; Operative treatment; Radiotherapy

Indexed keywords

ALKYLATING AGENT; AMINOGLUTETHIMIDE; BENZODIAZEPINE; CABERGOLINE; CORTICOTROPIN; DEXAMETHASONE; DOPAMINE RECEPTOR STIMULATING AGENT; ETOMIDATE; FLUINDOSTATIN; GLUCOCORTICOID RECEPTOR ANTAGONIST; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KETOCONAZOLE; LORAZEPAM; METYRAPONE; MIFEPRISTONE; MITOTANE; NIFEDIPINE; OCTREOTIDE; PASIREOTIDE; PHENYTOIN; PIOGLITAZONE; PRAVASTATIN; ROSIGLITAZONE; SOMATOSTATIN DERIVATIVE; TEMOZOLOMIDE; THEOPHYLLINE; UNINDEXED DRUG; VERAPAMIL; WARFARIN;

EID: 84857018658     PISSN: 11795549     EISSN: 11795549     Source Type: Journal    
DOI: 10.4137/CMO.S6198     Document Type: Review
Times cited : (14)

References (97)
  • 1
    • 9144250366 scopus 로고    scopus 로고
    • Diagnosis and complications of Cushing's syndrome: A consensus statement
    • Arnaldi G, Angeli A, Atkinson AB, et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2003;88:5593-5602.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 5593-5602
    • Arnaldi, G.1    Angeli, A.2    Atkinson, A.B.3
  • 2
    • 58149389462 scopus 로고    scopus 로고
    • The medical treatment of Cushing's disease: Effectiveness of chronic treatment with the dopamine agonist cabergoline inpatients unsuccessfully treated by surgery
    • Pivonello R, de Martino MC, Cappabianca P, et al. The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline inpatients unsuccessfully treated by surgery. J Clin Endocrinol Metab. 2009;94:223-230.
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 223-230
    • Pivonello, R.1    de Martino, M.C.2    Cappabianca, P.3
  • 3
    • 58149383820 scopus 로고    scopus 로고
    • Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): A multicenter, phase II trial
    • Boscaro M, Ludlam WH, Atkinson B, et al. Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. J Clin Endocrinol Metab. 2009;94:115-122.
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 115-122
    • Boscaro, M.1    Ludlam, W.H.2    Atkinson, B.3
  • 4
    • 33749548793 scopus 로고    scopus 로고
    • Cushing's syndrome: Important issues in diagnosis and management
    • Findling JW, Raff H. Cushing's syndrome: important issues in diagnosis and management. J Clin Endocrinol Metab. 2006;91:3746-3753.
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 3746-3753
    • Findling, J.W.1    Raff, H.2
  • 5
    • 0028339489 scopus 로고
    • Morbidity and mortality in Cushing's disease: An epidemiological approach
    • Etxabe J, Vazquez JA. Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol. 1993;40:479-484.
    • (1993) Clin Endocrinol , vol.40 , pp. 479-484
    • Etxabe, J.1    Vazquez, J.A.2
  • 6
    • 78651465378 scopus 로고    scopus 로고
    • Demographic factors and the presence of comorbidities do not promote early detection of Cushing's disease and acromegaly
    • Psaras T, Milian M, Hattermann V, Freiman T, Gallwitz B, Honegger J. Demographic factors and the presence of comorbidities do not promote early detection of Cushing's disease and acromegaly. Exp Clin Endocrinol Diabetes. 2011;119:21-25.
    • (2011) Exp Clin Endocrinol Diabetes , vol.119 , pp. 21-25
    • Psaras, T.1    Milian, M.2    Hattermann, V.3    Freiman, T.4    Gallwitz, B.5    Honegger, J.6
  • 8
    • 33845487765 scopus 로고
    • The natural history of Cushing's Syndrome
    • Plotz CM, Knowlton AI, Ragan C. The natural history of Cushing's Syndrome. Am J Med. 1952;13:597-614.
    • (1952) Am J Med , vol.13 , pp. 597-614
    • Plotz, C.M.1    Knowlton, A.I.2    Ragan, C.3
  • 9
    • 0019997417 scopus 로고
    • Cushing's syndrome-killing disease: Discriminatory value of signs and symptoms aiding early diagnosis
    • Ross EJ, Linch DC. Cushing's syndrome-killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet. 1982;2: 646-649.
    • (1982) Lancet , vol.2 , pp. 646-649
    • Ross, E.J.1    Linch, D.C.2
  • 10
    • 34548554688 scopus 로고    scopus 로고
    • Glucocorticoid-induced osteoporosis: Pathophysiology and therapy
    • Review
    • Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007;18: 1319-1328. Review.
    • (2007) Osteoporos Int , vol.18 , pp. 1319-1328
    • Canalis, E.1    Mazziotti, G.2    Giustina, A.3    Bilezikian, J.P.4
  • 14
    • 47549104969 scopus 로고    scopus 로고
    • Treatment of adrenocorticotropin- dependent Cushing's syndrome: A consensus statement
    • Biller BMK, Grossman AB, Stewart PM, et al. Treatment of adrenocorticotropin- dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2008;93:2454-2462.
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 2454-2462
    • Biller, B.M.K.1    Grossman, A.B.2    Stewart, P.M.3
  • 15
    • 10344252276 scopus 로고    scopus 로고
    • Transsphenoidal micro-surgery for Cushing's disease: Initial outcome and long-term results
    • Hammer GD, Tyrrell JB, Lamborn KR, et al. Transsphenoidal micro-surgery for Cushing's disease: initial outcome and long-term results. J Clin Endocrinol Metab. 2004;89:6348-6357.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 6348-6357
    • Hammer, G.D.1    Tyrrell, J.B.2    Lamborn, K.R.3
  • 16
    • 0032897746 scopus 로고    scopus 로고
    • Long-term mortality after transsphenoidal surgery for Cushing disease
    • Swearingen B, Biller BMK, Barker FG, et al. Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med. 1999;130:821-824.
    • (1999) Ann Intern Med , vol.130 , pp. 821-824
    • Swearingen, B.1    Biller, B.M.K.2    Barker, F.G.3
  • 17
    • 0036948120 scopus 로고    scopus 로고
    • Endoscopic endonasal transsphenoidal approach: Outcome analysis of 100 consecutive procedures
    • Cappabianca P, Cavallo LM, Colao A, et al. Endoscopic endonasal transsphenoidal approach: outcome analysis of 100 consecutive procedures. Minim Invasive Neurosurg. 2002;45:193-200.
    • (2002) Minim Invasive Neurosurg , vol.45 , pp. 193-200
    • Cappabianca, P.1    Cavallo, L.M.2    Colao, A.3
  • 18
    • 77956181344 scopus 로고    scopus 로고
    • Endocrine outcome in endoscopic pituitary surgery: A literature review
    • Dorward NL. Endocrine outcome in endoscopic pituitary surgery: a literature review. Acta Neurochir. 2010;152:1275-1279.
    • (2010) Acta Neurochir , vol.152 , pp. 1275-1279
    • Dorward, N.L.1
  • 19
    • 0037405212 scopus 로고    scopus 로고
    • Transsphenoidal microsurgical treatment of Cushing's disease: Postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test
    • Chen JCT, Amar AP, Choi S, et al. Transsphenoidal microsurgical treatment of Cushing's disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J Neurosurg. 2003;98:967-973.
    • (2003) J Neurosurg , vol.98 , pp. 967-973
    • Chen, J.C.T.1    Amar, A.P.2    Choi, S.3
  • 20
    • 1642359325 scopus 로고    scopus 로고
    • Transsphenoidal surgery in Cushing disease: 10 years of experience in 34 consecutive cases
    • Höybye C, Grenbäck E, Thorén M, et al. Transsphenoidal surgery in Cushing disease: 10 years of experience in 34 consecutive cases. J Neurosurg. 2004;100:634-638.
    • (2004) J Neurosurg , vol.100 , pp. 634-638
    • Höybye, C.1    Grenbäck, E.2    Thorén, M.3
  • 21
    • 0025766478 scopus 로고
    • Transnasal microsurgery of Cushing's disease: Overview including personal experience with 256 patients
    • Lüdecke DK. Transnasal microsurgery of Cushing's disease: overview including personal experience with 256 patients. Path Res Pract. 1991;187: 608-612.
    • (1991) Path Res Pract , vol.187 , pp. 608-612
    • Lüdecke, D.K.1
  • 22
    • 38649136956 scopus 로고    scopus 로고
    • Prospective Evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease
    • Rollin G, Ferreira NP, Czepielewski MA. Prospective Evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease. Arq Bras Endocrinol Metab. 2007;51:1355-61.
    • (2007) Arq Bras Endocrinol Metab , vol.51 , pp. 1355-1361
    • Rollin, G.1    Ferreira, N.P.2    Czepielewski, M.A.3
  • 23
    • 84857834032 scopus 로고    scopus 로고
    • Contemporary microsurgical concept for the treatment of Cushing's disease: Endocrine outcome in 83 consecutive patients
    • doi: 10.1111/j.1365-2265.2011.04268.x
    • Honegger J, Schmalisch K, Beuschlein F, Kaufmann S, Naegele T, Psaras T. Contemporary microsurgical concept for the treatment of Cushing's disease: Endocrine outcome in 83 consecutive patients. Clin Endocrinol (Oxf). 2011. doi: 10.1111/j.1365-2265.2011.04268.x.
    • (2011) Clin Endocrinol (Oxf)
    • Honegger, J.1    Schmalisch, K.2    Beuschlein, F.3    Kaufmann, S.4    Naegele, T.5    Psaras, T.6
  • 24
  • 25
    • 0036224824 scopus 로고    scopus 로고
    • Longterm follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission
    • Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF. Longterm follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission. Clin Endocrinol (Oxf). 2002;56:541-551.
    • (2002) Clin Endocrinol (Oxf) , vol.56 , pp. 541-551
    • Rees, D.A.1    Hanna, F.W.2    Davies, J.S.3    Mills, R.G.4    Vafidis, J.5    Scanlon, M.F.6
  • 26
    • 10344252276 scopus 로고    scopus 로고
    • Transsphenoidal microsurgery for Cushing's disease: Initial outcome and long-term results
    • Hammer GD, Tyrrell JB, Lamborn KR, et al. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. J Clin Endocrinol Metab. 2004;89:6348-6357.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 6348-6357
    • Hammer, G.D.1    Tyrrell, J.B.2    Lamborn, K.R.3
  • 27
    • 55949126195 scopus 로고    scopus 로고
    • Management of Cushing's disease: Outcome in patients with microadenoma detected on pituitary magnetic resonance imaging
    • Prevedello DM, Pouratian N, Sherman J, et al. Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging. J Neurosurg. 2008;109:751-759.
    • (2008) J Neurosurg , vol.109 , pp. 751-759
    • Prevedello, D.M.1    Pouratian, N.2    Sherman, J.3
  • 28
    • 38149022450 scopus 로고    scopus 로고
    • Long-term results after microsurgery for Cushing disease: Experience with 426 primary operations over 35 years
    • Hofmann BM, Hlavac M, Martinez R, et al. Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. J Neurosurg. 2008;108:9-18.
    • (2008) J Neurosurg , vol.108 , pp. 9-18
    • Hofmann, B.M.1    Hlavac, M.2    Martinez, R.3
  • 29
    • 38649136956 scopus 로고    scopus 로고
    • Prospective Evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease
    • Rollin G, Ferreira NP, Czepielewski MA. Prospective Evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease. Arq Bras Endocrinol Metab. 2007;51:1355-1361.
    • (2007) Arq Bras Endocrinol Metab , vol.51 , pp. 1355-1361
    • Rollin, G.1    Ferreira, N.P.2    Czepielewski, M.A.3
  • 30
    • 57349122063 scopus 로고    scopus 로고
    • Selective use of bilateral inferior petrosal sinus sampling in patients with adrenocorticotropin-dependent Cushing's syndrome prior to transsphenoidal surgery
    • Jehle S, Walsch JE, Freda PU, et al. Selective use of bilateral inferior petrosal sinus sampling in patients with adrenocorticotropin-dependent Cushing's syndrome prior to transsphenoidal surgery. J Clin Endocrinol Metab. 2008;93:4624-4632.
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 4624-4632
    • Jehle, S.1    Walsch, J.E.2    Freda, P.U.3
  • 31
    • 0037238410 scopus 로고    scopus 로고
    • Accuracy of bilateral inferior petrosal or cavernous sinuses sampling in predicting the lateralization of Cushing's disease pituitary microadenoma: Influence of catheter position and anatomy of venous drainage
    • Lefournier V, Martinie M, Vasdev A, Bessou P, Passagia JG, Labat-Moleur F, et al. Accuracy of bilateral inferior petrosal or cavernous sinuses sampling in predicting the lateralization of Cushing's disease pituitary microadenoma: influence of catheter position and anatomy of venous drainage. J Clin Endocrinol Metab. 2003;88:196-203.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 196-203
    • Lefournier, V.1    Martinie, M.2    Vasdev, A.3    Bessou, P.4    Passagia, J.G.5    Labat-Moleur, F.6
  • 32
    • 0026042714 scopus 로고
    • Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome
    • Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, et al. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med. 1991;325:897-905.
    • (1991) N Engl J Med , vol.325 , pp. 897-905
    • Oldfield, E.H.1    Doppman, J.L.2    Nieman, L.K.3    Chrousos, G.P.4    Miller, D.L.5    Katz, D.A.6
  • 33
    • 27744474039 scopus 로고    scopus 로고
    • Long-term remission rates after pituitary surgery for Cushing's disease: The need for long-term surveillance
    • Atkinson AB, Kennedy A, Wiggam MI, McCance DR, Sheridan B. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Clin Endocrinol (Oxf). 2005;63:549-559.
    • (2005) Clin Endocrinol (Oxf) , vol.63 , pp. 549-559
    • Atkinson, A.B.1    Kennedy, A.2    Wiggam, M.I.3    McCance, D.R.4    Sheridan, B.5
  • 34
    • 77950686021 scopus 로고    scopus 로고
    • Usefulness of composite methionine-positron emission tomography/3.0-tesla magnetic resonance imaging to detect the localization and extent of early-stage Cushing adenoma
    • Ikeda H, Abe T, Watanabe K. Usefulness of composite methionine-positron emission tomography/3.0-tesla magnetic resonance imaging to detect the localization and extent of early-stage Cushing adenoma. J Neurosurg. 2010;112:750-755.
    • (2010) J Neurosurg , vol.112 , pp. 750-755
    • Ikeda, H.1    Abe, T.2    Watanabe, K.3
  • 35
    • 0029690143 scopus 로고    scopus 로고
    • Persistent and recurrent hypercortisolism after transsphenoidal surgery for Cushing's disease
    • Knappe UJ, Lüdecke DK. Persistent and recurrent hypercortisolism after transsphenoidal surgery for Cushing's disease. Acta Neurochir [Suppl]. 1996;65:31-34.
    • (1996) Acta Neurochir [Suppl] , vol.65 , pp. 31-34
    • Knappe, U.J.1    Lüdecke, D.K.2
  • 37
    • 24344492347 scopus 로고    scopus 로고
    • The strategy of immediate reoperation for transsphenoidal surgery for Cushing's disease
    • Locatelli M, Vance ML, Laws ER. The strategy of immediate reoperation for transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab. 2005;90:5478-5482.
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 5478-5482
    • Locatelli, M.1    Vance, M.L.2    Laws, E.R.3
  • 38
    • 0027398459 scopus 로고
    • Transsphenoidal resection in Cushing's disease: Undetectable serum cortisol as the definition of successful treatment
    • Trainer PJ, Lawrie HS, Verhelst J, Howlett TA, Lowe DG, Grossman AB, et al. Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf).1993;38:73-78.
    • (1993) Clin Endocrinol (Oxf) , vol.38 , pp. 73-78
    • Trainer, P.J.1    Lawrie, H.S.2    Verhelst, J.3    Howlett, T.A.4    Lowe, D.G.5    Grossman, A.B.6
  • 39
    • 64849098882 scopus 로고    scopus 로고
    • Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease
    • Pantil CG, Veeravagu A, Prevedello M, et al. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease. Neurosurgery. 2008;63: 266-271.
    • (2008) Neurosurgery , vol.63 , pp. 266-271
    • Pantil, C.G.1    Veeravagu, A.2    Prevedello, M.3
  • 40
    • 23144457218 scopus 로고    scopus 로고
    • Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma
    • Benveniste RJ, King WA, Walsch J, et al. Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma. J Neurosur. 2005;102: 1004-1012.
    • (2005) J Neurosur , vol.102 , pp. 1004-1012
    • Benveniste, R.J.1    King, W.A.2    Walsch, J.3
  • 41
    • 84856993679 scopus 로고    scopus 로고
    • Editor: Leon V. Berhardt, Nova Science Publishers, Inc
    • Ikeda H. Diagnosis of Cushing's disease. In: Advances in Medicine and Biology, Volume 23. Editor: Leon V. Berhardt, pp. 185-204. Nova Science Publishers, Inc. 2011.
    • (2011) Diagnosis of Cushing's Disease , vol.23 , pp. 185-204
    • Ikeda, H.1
  • 42
    • 0028096081 scopus 로고
    • Early repeat surgery for persistent Cushing's disease
    • Ram Z, Nieman LK, Cutler GB, et al. Early repeat surgery for persistent Cushing's disease. J Neurosurg. 1994;80:37-45.
    • (1994) J Neurosurg , vol.80 , pp. 37-45
    • Ram, Z.1    Nieman, L.K.2    Cutler, G.B.3
  • 43
    • 38649136956 scopus 로고    scopus 로고
    • Prospective Evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease
    • Rollin G, Ferreira NP, Czepielewski MA. Prospective Evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease. Arq Bras Endocrinol Metab. 2007;51:1355-61.
    • (2007) Arq Bras Endocrinol Metab , vol.51 , pp. 1355-1361
    • Rollin, G.1    Ferreira, N.P.2    Czepielewski, M.A.3
  • 44
    • 58549083956 scopus 로고    scopus 로고
    • Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: A good therapeutic option for recurrent or persistent Cushing's disease (CD)
    • Wagenmakers MAEM, Netea-Maier RT, van Lindert EJ, et al. Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD). Clin Endocrinol. 2009;70:274-80.
    • (2009) Clin Endocrinol , vol.70 , pp. 274-280
    • Wagenmakers, M.A.E.M.1    Netea-Maier, R.T.2    van Lindert, E.J.3
  • 46
    • 59149083923 scopus 로고    scopus 로고
    • Cushing's disease: Radiation therapy
    • Vance ML. Cushing's disease: radiation therapy. Pituitary. 2009;12:11-14.
    • (2009) Pituitary , vol.12 , pp. 11-14
    • Vance, M.L.1
  • 47
    • 0031022457 scopus 로고    scopus 로고
    • The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease
    • Estrada J, Boronat M, Mielgo M, et al. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease. N Engl J Med. 1997;336:172-177.
    • (1997) N Engl J Med , vol.336 , pp. 172-177
    • Estrada, J.1    Boronat, M.2    Mielgo, M.3
  • 49
    • 77950300238 scopus 로고    scopus 로고
    • Role of stereotactic radio-surgery in the management of pituitary adenomas
    • Castinetti F, Régis J, Dufour H, Brue T. Role of stereotactic radio-surgery in the management of pituitary adenomas. J Clin Endocrinol Metab. 2010;6: 214-223.
    • (2010) J Clin Endocrinol Metab , vol.6 , pp. 214-223
    • Castinetti, F.1    Régis, J.2    Dufour, H.3    Brue, T.4
  • 51
    • 0028055146 scopus 로고
    • Conventional fractionated radiation therapy versus radiosurgery
    • Markes LB. Conventional fractionated radiation therapy versus radiosurgery. J Neurooncol. 1993;17:223-230.
    • (1993) J Neurooncol , vol.17 , pp. 223-230
    • Markes, L.B.1
  • 52
    • 17844398230 scopus 로고    scopus 로고
    • Adrenocorti-cotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treament with stereotactic radiosurgery
    • Höybye C, Grenback A, Rahn T, Degerblad M, Thorén M, Hulting AL. Adrenocorti-cotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treament with stereotactic radiosurgery. Neurosurgery. 2001;49:284-291.
    • (2001) Neurosurgery , vol.49 , pp. 284-291
    • Höybye, C.1    Grenback, A.2    Rahn, T.3    Degerblad, M.4    Thorén, M.5    Hulting, A.L.6
  • 53
  • 58
    • 0036714594 scopus 로고    scopus 로고
    • Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: Factors associated with endocrine normalization
    • Pollock BE, Nippoldt TB, Stafford SL, Foote RL, Abboud CF. Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: factors associated with endocrine normalization. J Neurosurg. 2002;97:525-530.
    • (2002) J Neurosurg , vol.97 , pp. 525-530
    • Pollock, B.E.1    Nippoldt, T.B.2    Stafford, S.L.3    Foote, R.L.4    Abboud, C.F.5
  • 60
    • 40749086366 scopus 로고    scopus 로고
    • Bilateral laparoscopic adrenalectomy for corticotrophin-dependent Cushing's syndrome: A review of the Mayo Clinic experience
    • Chow JT, Thompson GB, Grant CS, Farley DR, Richards ML, Young WF Jr. Bilateral laparoscopic adrenalectomy for corticotrophin-dependent Cushing's syndrome: a review of the Mayo Clinic experience. Clin Endocrinol (Oxf). 2008;68:513-9.
    • (2008) Clin Endocrinol (Oxf) , vol.68 , pp. 513-519
    • Chow, J.T.1    Thompson, G.B.2    Grant, C.S.3    Farley, D.R.4    Richards, M.L.5    Young Jr., W.F.6
  • 61
    • 33846080239 scopus 로고    scopus 로고
    • Corticotroph tumor progression after adrenalectomy in Cushing's Disease: A reappraisal of Nelson's syndrome
    • Assié G, Bahurel H, Coste J, et al. Corticotroph tumor progression after adrenalectomy in Cushing's Disease: a reappraisal of Nelson's syndrome. J Clin Endocrinol Metab. 2007;92:172-179.
    • (2007) J Clin Endocrinol Metab , vol.92 , pp. 172-179
    • Assié, G.1    Bahurel, H.2    Coste, J.3
  • 62
    • 38449090257 scopus 로고    scopus 로고
    • Medical management of Cushing disease
    • Gross B, Mindea S, Pick A, et al. Medical management of Cushing disease. Neurosurg Focus. 2007;23:E10.
    • (2007) Neurosurg Focus , vol.23
    • Gross, B.1    Mindea, S.2    Pick, A.3
  • 63
    • 0027482984 scopus 로고
    • Different inhibitory effect of etomidate and keto-conazole on the human adrenal steroid biosynthesis
    • Weber M, Lang J, Abedinpour F, Zeilberger K, Adelmann B, Engelhardt D. Different inhibitory effect of etomidate and keto-conazole on the human adrenal steroid biosynthesis. Clin Investig. 1993;71:933-938.
    • (1993) Clin Investig , vol.71 , pp. 933-938
    • Weber, M.1    Lang, J.2    Abedinpour, F.3    Zeilberger, K.4    Adelmann, B.5    Engelhardt, D.6
  • 64
    • 0022815983 scopus 로고
    • Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis
    • Feldman D. Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis. Endocr Rev. 1986;7:409-420.
    • (1986) Endocr Rev , vol.7 , pp. 409-420
    • Feldman, D.1
  • 65
    • 0023273646 scopus 로고
    • The use of ketoconazole as an inhibitor of steroid production
    • Sonino N. The use of ketoconazole as an inhibitor of steroid production. N Engl J Med. 1987;317:812-818.
    • (1987) N Engl J Med , vol.317 , pp. 812-818
    • Sonino, N.1
  • 67
    • 0037024509 scopus 로고    scopus 로고
    • The medical management of Cushing's syndrome
    • Morris D, Grossman A. The medical management of Cushing's syndrome. Ann N Y Acad Sci. 2002;970:119-133.
    • (2002) Ann N Y Acad Sci , vol.970 , pp. 119-133
    • Morris, D.1    Grossman, A.2
  • 69
    • 0028067785 scopus 로고
    • Therapy of Cushing's syndrome with steroid biosynthesis inhibitors
    • Engelhardt D, Weber MM. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors. J Steroid Biochem Mol Biol. 1994;49:261-267.
    • (1994) J Steroid Biochem Mol Biol , vol.49 , pp. 261-267
    • Engelhardt, D.1    Weber, M.M.2
  • 70
    • 0017987335 scopus 로고
    • Metyrapone is useful only as adjunctive therapy in Cushing's disease
    • Orth DN. Metyrapone is useful only as adjunctive therapy in Cushing's disease. Ann Intern Med. 1978;89:128-130.
    • (1978) Ann Intern Med , vol.89 , pp. 128-130
    • Orth, D.N.1
  • 71
  • 72
    • 0025874647 scopus 로고
    • Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome
    • Verhelst JA, Trainer PJ, Howlett TA, Perry L, Rees LH, Grossman AB, et al. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome. Clin Endocrinol (Oxf). 1991;35: 169-178.
    • (1991) Clin Endocrinol (Oxf) , vol.35 , pp. 169-178
    • Verhelst, J.A.1    Trainer, P.J.2    Howlett, T.A.3    Perry, L.4    Rees, L.H.5    Grossman, A.B.6
  • 73
    • 0019724824 scopus 로고
    • Aminoglutethimide: Review of pharmacology and clinical use
    • Santen RJ, Misbin RI. Aminoglutethimide: review of pharmacology and clinical use. Pharmacotherapy. 1981;1:95-120.
    • (1981) Pharmacotherapy , vol.1 , pp. 95-120
    • Santen, R.J.1    Misbin, R.I.2
  • 74
    • 0017752884 scopus 로고
    • Adrenal suppression with aminoglutethimide. I. Differential effects of aminoglutethimide on glucocorticoid metabolism as a rationale for use of hydrocortisone
    • Santen RJ, Wells SA, Runic S, Gupta C, Kendall J, Rudy EB, et al. Adrenal suppression with aminoglutethimide. I. Differential effects of aminoglutethimide on glucocorticoid metabolism as a rationale for use of hydrocortisone. J Clin Endocrinol Metab. 1977;45:469-479.
    • (1977) J Clin Endocrinol Metab , vol.45 , pp. 469-479
    • Santen, R.J.1    Wells, S.A.2    Runic, S.3    Gupta, C.4    Kendall, J.5    Rudy, E.B.6
  • 75
    • 0015063322 scopus 로고
    • Studies on the site of action of o, ṕ-DDD in the dog adrenal cortex. 1. Inhibition of ACTH-mediated pregnenolone synthesis
    • May
    • Hart MM, Straw JA. Studies on the site of action of o, ṕ-DDD in the dog adrenal cortex. 1. Inhibition of ACTH-mediated pregnenolone synthesis. Steroids. May 1971;17(5):559-74.
    • (1971) Steroids , vol.17 , Issue.5 , pp. 559-574
    • Hart, M.M.1    Straw, J.A.2
  • 76
    • 0036933584 scopus 로고    scopus 로고
    • Medical therapy of Cushing's disease
    • Nieman LK. Medical therapy of Cushing's disease. Pituitary. 2002;5:77-82.
    • (2002) Pituitary , vol.5 , pp. 77-82
    • Nieman, L.K.1
  • 81
    • 0024582944 scopus 로고
    • The protracted effect of o, p'-DDD in Cushing's disease and its impact on adrenal morphogenesis of young human embryo
    • Leiba S, Weinstein R, Shindel B, Lapidot M, Stern E, Levavi H, et al. The protracted effect of o, p'-DDD in Cushing's disease and its impact on adrenal morphogenesis of young human embryo. Ann Endocrinol (Paris). 1989;50:49-53.
    • (1989) Ann Endocrinol (Paris) , vol.50 , pp. 49-53
    • Leiba, S.1    Weinstein, R.2    Shindel, B.3    Lapidot, M.4    Stern, E.5    Levavi, H.6
  • 82
    • 0031769470 scopus 로고    scopus 로고
    • Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitis
    • Drake WM, Perry LA, Hinds CJ, Lowe DG, Reznek RH, Besser GM. Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitis. J Clin Endocrinol Metab. 1998;83:3542-3544.
    • (1998) J Clin Endocrinol Metab , vol.83 , pp. 3542-3544
    • Drake, W.M.1    Perry, L.A.2    Hinds, C.J.3    Lowe, D.G.4    Reznek, R.H.5    Besser, G.M.6
  • 84
    • 85011465009 scopus 로고    scopus 로고
    • Cell specific expression of the sst2A and sst5 somatostatin receptors in the rat anterior pituitary
    • Mezey E, Hunyady B, Mitra S, Hayes E, Liu Q, Schaeffer J, et al. Cell specific expression of the sst2A and sst5 somatostatin receptors in the rat anterior pituitary. Endocrinology. 1998;139:414-419.
    • (1998) Endocrinology , vol.139 , pp. 414-419
    • Mezey, E.1    Hunyady, B.2    Mitra, S.3    Hayes, E.4    Liu, Q.5    Schaeffer, J.6
  • 85
    • 20244376493 scopus 로고    scopus 로고
    • The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5
    • Hofland LJ, van der Hoek J, Feelders R, van Aken MO, van Koetsveld PM, Waaijers M, et al. The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5. Eur J Endocrinol. 2005;152:645-654.
    • (2005) Eur J Endocrinol , vol.152 , pp. 645-654
    • Hofland, L.J.1    van der Hoek, J.2    Feelders, R.3    van Aken, M.O.4    van Koetsveld, P.M.5    Waaijers, M.6
  • 86
    • 33751532708 scopus 로고    scopus 로고
    • The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas
    • Batista DL, Zhang X, Gejman R, Ansell PJ, Zhou Y, Johnson SA, et al. The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas. J Clin Endocrinol Metab. 2006;91:4482-4488.
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 4482-4488
    • Batista, D.L.1    Zhang, X.2    Gejman, R.3    Ansell, P.J.4    Zhou, Y.5    Johnson, S.A.6
  • 87
    • 67349112176 scopus 로고    scopus 로고
    • Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome
    • de Bruin C, Feelders RA, Lamberts SW, Hofland LJ. Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome. Rev Endocr Metab Disord. 2009;10:91-102.
    • (2009) Rev Endocr Metab Disord , vol.10 , pp. 91-102
    • de Bruin, C.1    Feelders, R.A.2    Lamberts, S.W.3    Hofland, L.J.4
  • 88
    • 0032230258 scopus 로고    scopus 로고
    • Absence of dopaminergic control on melanotrophs leads to Cushing's-like syndrome in mice
    • Saiardi A, Borrelli E. Absence of dopaminergic control on melanotrophs leads to Cushing's-like syndrome in mice. Mol Endocrinol. 1998;12:1133-1139.
    • (1998) Mol Endocrinol , vol.12 , pp. 1133-1139
    • Saiardi, A.1    Borrelli, E.2
  • 89
    • 2442610476 scopus 로고    scopus 로고
    • Dopamine receptor expression and function in corticotroph pituitary tumors
    • Pivonello R, Ferone D, de Herder WW, et al. Dopamine receptor expression and function in corticotroph pituitary tumors. J Clin Endocrinol Metab. 2004;89:2452-2462.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 2452-2462
    • Pivonello, R.1    Ferone, D.2    de Herder, W.W.3
  • 91
    • 35848967790 scopus 로고    scopus 로고
    • Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA
    • De Marinis L, Bianchi A, Fusco A, Cimino V, Mormando M, Tilaro L, et al. Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA. Pituitary. 2007;10:227-232.
    • (2007) Pituitary , vol.10 , pp. 227-232
    • de Marinis, L.1    Bianchi, A.2    Fusco, A.3    Cimino, V.4    Mormando, M.5    Tilaro, L.6
  • 92
    • 4444233036 scopus 로고    scopus 로고
    • Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease
    • Ambrosi B, Dall'Asta C, Cannavo S, Libe R, Vigo T, Epaminonda P, et al. Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease. Eur J Endocrinol. 2004;151:173-178.
    • (2004) Eur J Endocrinol , vol.151 , pp. 173-178
    • Ambrosi, B.1    Dall'asta, C.2    Cannavo, S.3    Libe, R.4    Vigo, T.5    Epaminonda, P.6
  • 93
    • 33645025854 scopus 로고    scopus 로고
    • Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease
    • Pecori Giraldi F, Scaroni C, Arvat E, Martin M, Giordano R, Albiger N, et al. Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease. Clin Endocrinol (Oxf). 2006;64:219-224.
    • (2006) Clin Endocrinol (Oxf) , vol.64 , pp. 219-224
    • Pecori, G.F.1    Scaroni, C.2    Arvat, E.3    Martin, M.4    Giordano, R.5    Albiger, N.6
  • 94
    • 78049301554 scopus 로고    scopus 로고
    • MGMT immunoexpression in aggressive pituitary adenoma and carcinoma
    • Review
    • Lau Q, Scheithauer B, Kovacs K, Horvath E, Syro LV, Lloyd R. MGMT immunoexpression in aggressive pituitary adenoma and carcinoma. Pituitary. 2010;13:367-379.Review.
    • (2010) Pituitary , vol.13 , pp. 367-379
    • Lau, Q.1    Scheithauer, B.2    Kovacs, K.3    Horvath, E.4    Syro, L.V.5    Lloyd, R.6
  • 96
    • 80052633961 scopus 로고    scopus 로고
    • Aggressive pituitary tumours: The role of temozolomide and the assessment of MGMT status
    • McCormack AI, Wass JA, Grossman AB. Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status. Eur J Clin Invest. 2011;41:1133-1148.
    • (2011) Eur J Clin Invest , vol.41 , pp. 1133-1148
    • McCormack, A.I.1    Wass, J.A.2    Grossman, A.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.